PI3K pathway is frequently disrupted in breast cancer; in particular the p110α subunit is often mutated at specific hot spots whereas PTEN expression is often abolished, all leading to a constitutive activation of the PI3K pathway. The gene discussed is PTEN; the disease is breast carcinoma.